| Price | $13.85 |
| Year Range | $8.75 – $35.07 |
| Market Cap | $17M |
| Industry | Biotechnology |
What Is Sensei Biotherapeutics’s AI Stock Analysis?
Sensei Biotherapeutics’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Sensei Biotherapeutics’s momentum in near-real time.
Sensei Biotherapeutics (SNSE) has an AltIndex AI Score of 62/100, currently a Buy signal. The AI Score distills Sensei Biotherapeutics's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Sensei Biotherapeutics’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Sensei Biotherapeutics — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving SNSE’s AI Score?
Fundamentals
Net income for the last quarter was $-170M. This represents a decrease of 3,509.75% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 2,380.13%, which may be a cause for concern. Ebitda for the last quarter was $-171M. This represents a decrease of 3,545.88% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 2,401.50%, which may be a cause for concern.
See Sensei Biotherapeutics’s earnings and insider transactions.
Technicals
Today's stock price is $13.85. This is equal to the stock price a month ago, showing short-term stability. Compared to a year ago, there is an increase of 23.00%, suggesting a positive long-term trend. The trend is neutral. The current SMA10 of $13.85 is equal to the previous SMA10, indicating no significant change in the trend. The RSI is 47.5, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
The business outlook among employees at Sensei Biotherapeutics is very high (an estimate of 100% of employees have a positive outlook), a positive sign. Sensei Biotherapeutics has an estimate of 0 visitors to their webpage. The number of visitors is down by -100% in the last couple of months, a worrisome trend as this can indicate a loss in customers.
Explore Sensei Biotherapeutics’s job postings, web traffic and app downloads.
Frequently Asked Questions: Sensei Biotherapeutics AI Stock Analysis
Sensei Biotherapeutics's AltIndex AI Score is 62/100, currently a Buy signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Sensei Biotherapeutics a Buy (62/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Sensei Biotherapeutics — company overview, fundamentals, technicals and alternative data, with a recommendation. See the SNSE AI Score or sign up to read the full thesis.
